Toll‐like receptor 7 stimulates production of specialized pro‐resolving lipid mediators and promotes resolution of airway inflammation
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Although specialized pro‐resolving mediators (SPMs) biosynthesized from polyunsaturated fatty acids are critical for the resolution of acute inflammation, the molecules and pathways that induce their production remain elusive. Here, we show that TLR7, a receptor recognizing viral ssRNA and damaged self‐RNA, mobilizes the docosahexaenoic acid (DHA)‐derived biosynthetic pathways that lead to the generation of D‐series SPMs. In mouse macrophages and human monocytes, TLR7 activation triggered production of DHA‐derived monohydroxy metabolome markers and generation of protectin D1 (PD1) and resolvin D1 (RvD1). In mouse allergic airway inflammation, TLR7 activation enhanced production of DHA‐derived SPMs including PD1 and accelerated the catabasis of Th2‐mediated inflammation. D‐series SPMs were critical for TLR7‐mediated resolution of airway inflammation as this effect was lost in Alox15 −/− mice, while resolution was enhanced after local administration of PD1 or RvD1. Together, our findings reveal a new previously unsuspected role of TLR7 in the generation of D‐series SPMs and the resolution of allergic airway inflammation. They also identify TLR stimulation as a new approach to drive SPMs and resolution of inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Self-citationNathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183 · cited 2×
“Prolonged or non-resolving inflammation underlies the pathogenesis of a wide range of virtually unrelated diseases ranging from autoimmune, metabolic and neurological disorders to allergies (Medzhitov, 2008; Nathan & Ding, 2010).”
Asthma: From Bronchoconstriction to Airways Inflammation and Remodeling
BOUSQUET, J., JEFFERY, P. K., BUSSE, W. W., JOHNSON, M., & VIGNOLA, A. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9903102 · Cited by 1,702 · cited 1×
“Although the intensity and duration of Th2 exacerbations determine the severity of the asthmatic attack (Bousquet et al, 2000; Jackson et al, 2011; Locksley, 2010), the molecular mechanisms and pathways controlling persistence or resolution of Th2 allergic responses in the airways are largely…”
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045 · cited 2×
“We found significant increases in 7-hydroxydocosahexaenoic acid (d5-7-HDHA), d5-14-HDHA and d5-17-HDHA (Fig 5), rate-limiting components in the metabolism of DHA to its bioactive derivatives (Hong et al, 2003; Miyata et al, 2013; Serhan et al, 2006).”
Self-citationHong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000 · cited 3×
“We found significant increases in 7-hydroxydocosahexaenoic acid (d5-7-HDHA), d5-14-HDHA and d5-17-HDHA (Fig 5), rate-limiting components in the metabolism of DHA to its bioactive derivatives (Hong et al, 2003; Miyata et al, 2013; Serhan et al, 2006).”
Self-citationTherapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869 · cited 2×
“As several TLR7 or TLR7/8 agonists are under clinical development for the treatment of various diseases including respiratory allergies (Hennessy et al, 2010; Kanzler et al, 2007), their efficacy in clinical trials of allergic asthma exacerbations are eagerly awaited.”
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802 · cited 1×
“…cells and infiltrating leukocytes that carry esterified DHA in membrane phospholipids (such as phosphatidylethanolamine and phosphatidylcholine), and oedema which provides unesterified DHA to local sites of inflammation (Hong et al, 2003; Kasuga et al, 2008; Marcheselli et al, 2003; Serhan, 2010).”
Self-citationMolecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins
Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., Hong, S., & Serhan, C. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4345 · Cited by 699
Self-citationInfection regulates pro-resolving mediators that lower antibiotic requirements
Chiang, N., Fredman, G., Bäckhed, F., Oh, S. F., Vickery, T., Schmidt, B. A., & Serhan, C. N. (2012) · Nature · doi:10.1038/nature11042 · Cited by 664 · cited 2×
“the antimicrobial defence and enhance bacterial phagocytosis from macrophages and neutrophils without stimulating uncontrolled inflammation and collateral tissue damage (Chiang et al, 2012) or mediating immunosuppression (Norris & Dennis, 2012; Serhan, 2007; Serhan et al, 2008).”
Self-citationNovel Lipid Mediators and Resolution Mechanisms in Acute Inflammation
Serhan, C. N. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100322 · Cited by 421 · cited 2×
“…cells and infiltrating leukocytes that carry esterified DHA in membrane phospholipids (such as phosphatidylethanolamine and phosphatidylcholine), and oedema which provides unesterified DHA to local sites of inflammation (Hong et al, 2003; Kasuga et al, 2008; Marcheselli et al, 2003; Serhan, 2010).”
Self-citationEdwards, M. R., Bartlett, N. W., Hussell, T., Openshaw, P., & Johnston, S. L. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2801 · Cited by 205 · cited 1×
“Among them, Toll-like receptors (TLRs) have taken centre stage by virtue of their ability to recognize common allergens, microbial structures and endogenous ‘danger’ signals, and promote pro-inflammatory responses in the airways (Edwards et al, 2012; Palm et al, 2012).”
Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling
Norris, P. C., & Dennis, E. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200189109 · Cited by 193
VTX-1463, a novel TLR8 agonist for the treatment of allergic rhinitis
Horak, F. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.583237 · Cited by 51 · cited 1×
“Placebo-controlled phase II study shows CYT003-QbG10 is safe and efficacious for the treatment of allergic asthma. http://www.cytos.ch/?id=1572), rhinitis (Horak, 2011) or rhinoconjunctivitis (Klimek et al, 2011), yet the mechanistic basis for these effects is lacking.”
Cited by
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583
Self-citationSerhan, C. N., Dalli, J., Colas, R. A., Winkler, J. W., & Chiang, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.006 · Cited by 492
Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases
Spite, M., Clària, J., & Serhan, C. N. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.006 · Cited by 464
Self-citationCelebi Sozener, Z., Ozdel Ozturk, B., Cerci, P., Turk, M., Gorgulu Akin, B., Akdis, M., Altiner, S., Ozbey, U., Ogulur, I., Mitamura, Y., et al. (2022) · Allergy · doi:10.1111/all.15240 · Cited by 418
Chiang, N., & Serhan, C. N. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.005 · Cited by 324
Self-citation
Metadata
- Authors
- Koltsida, O., Karamnov, S., Pyrillou, K., Vickery, T., Chairakaki, A., Tamvakopoulos, C., Sideras, P., Serhan, C. N., & Andreakos, E.
- Venue
- EMBO Molecular Medicine
- Published
- 2013-04-15
- Volume
- 5
- Issue
- 5
- Pages
- 762-775
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2107821069
- Cited by
- 72
- References
- 13
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.